Scholar Rock Reports New Employee Incentive Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company developing innovative treatments for spinal muscular atrophy, cardiometabolic disease and other serious diseases in which protein growth factors play a fundamental role, today announced that the Company has granted three newly hired employees incentive stock awards totaling 407,000 shares of its common stock, consisting of incentive stock options to purchase an aggregate of 232,571 shares of common stock and incentive restricted stock units totaling 174,429 shares of common stock.

The Awards are subject to all terms and conditions set forth in the Company’s 2022 Inducement Equity Plan (the “Plan”) and related award agreements.